Feature

The financial impact of defining illnesses as acute or chronic can mean some policyholders go without the care they need. Dave Priestley delves into an emotional area

In the wake of shock pre-Budget revelations possibly marking the end of PTA, Lucy Quinton reports on industry predictions for 2007 from the latest COVER survey

Survey: Majority believe a generic campaign and media push are essential

NEWCOB is a bold step towards a principles-based era, but while some see it as a chance for the industry to evolve, others think nothing much will change. Sam Barrett investigates

While non-disclosure is one of the main reasons a claim is declined, consumers still do not think they should be rejected when the facts left out are non-linked, writes Warren Copp

Chronic obstructive pulmonary disease is a respiratory condition affecting a worrying percentage of the British population, says Rachel Hanslope

Following the recent publication of Defaqto's annual income protection report, Nick Telfer takes a closer look at the issues surrounding the misunderstood cover

With the UK still behind the US on underwriting stringency, is it time to up the tempo and introduce a non-contestability clause as a remedy to non-disclosure? Edward Murray reports

The A-Day changes have made PTA product of the day for all market advisers, but in being too specialised does it mean sour grapes for others? Samantha Downes investigates

There are so many aspects of a business that require protection so why are advisers shunning this sector? Alun Beynon investigates